Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$20.6M Sell
1,436,000
-340,000
-19% -$4.42M 13.04% 1
2017
Q3
$21.7M Buy
+1,776,000
New +$31.4M 8.9% 2

Other funds holding DXCM

IPL Advisers's DXCM Position: Q4 2017 in Review

IPL Advisers reduced its DexCom (DXCM) stake by 19% in Q4 2017, selling an estimated $4.42M and leaving 1,436,000 shares worth $20.6M. The position accounts for 13.04% of the portfolio, ranked #1.

IPL Advisers first reported a position in DXCM in Q3 2017 and has held it in 2 quarters since. The position peaked at $21.7M in Q3 2017. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

  • IPL Advisers held 1,436,000 shares of DexCom worth $20.6M as of Q4 2017.
  • IPL Advisers sold 340,000 DexCom shares in Q4 2017, an estimated $4.42M.
  • DexCom made up 13.04% of IPL Advisers's portfolio in Q4 2017, its #1 holding.
  • IPL Advisers first reported a position in DexCom in Q3 2017 and has held it in 2 quarters since.
  • IPL Advisers's DexCom position peaked at $21.7M in Q3 2017.
  • 273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on IPL Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.